Eagle Pharmaceuticals Revenue 2013-2019 | EGRX

Eagle Pharmaceuticals revenue from 2013 to 2019. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
Eagle Pharmaceuticals Annual Revenue
(Millions of US $)
2019 $196
2018 $213
2017 $237
2016 $189
2015 $66
2014 $
2014 $19
2013 $14
2012 $
2012 $3
2011 $3
Eagle Pharmaceuticals Quarterly Revenue
(Millions of US $)
2019-12-31 $48
2019-09-30 $41
2019-06-30 $57
2019-03-31 $50
2018-12-31 $56
2018-09-30 $51
2018-06-30 $59
2018-03-31 $47
2017-12-31 $47
2017-09-30 $63
2017-06-30 $50
2017-03-31 $77
2016-12-31 $81
2016-09-30 $38
2016-06-30 $41
2016-03-31 $30
2015-12-31 $18
2015-09-30 $6
2015-06-30 $6
2015-03-31 $36
2014-12-31 $6
2014-09-30 $3
2014-06-30 $6
2014-03-31 $5
2013-12-31 $5
2013-09-30 $5
2013-06-30 $5
2013-03-31 $2
2012-09-30
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.650B $0.196B
Eagle Pharmaceuticals, Inc. is a specialty pharmaceutical company. It focuses on developing and commercializing injectable products primarily in the critical care and oncology areas in the United States. The Company markets EP-1101 to treat heparin-induced thrombocytopenia. It develops EP-3101, EP-3102, Ryanodex and EP-4104. Eagle Pharmaceuticals, Inc. is based in Woodcliff Lake, New Jersey.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $149.804B 26.22
Medtronic (MDT) Ireland $133.052B 17.89
Stryker (SYK) United States $66.131B 21.36
Boston Scientific (BSX) United States $49.048B 22.09
Baxter (BAX) United States $42.854B 26.15
Coloplast (CLPBY) Denmark $31.342B 48.37
Lonza Group Ag (LZAGY) Switzerland $31.005B 0.00
Terumo (TRUMY) Japan $25.452B 0.00
EssilorLuxottica Societe Anonyme (ESLOY) France $24.971B 0.00
Zimmer Biomet Holdings (ZBH) United States $22.969B 14.14
ResMed (RMD) United States $22.439B 38.99
Smith & Nephew SNATS (SNN) United Kingdom $16.862B 0.00
Sunny Optical Technology (SNPTF) China $15.926B 0.00
Bio-Rad Laboratories (BIO) United States $12.061B 56.37
Insulet (PODD) United States $11.056B 676.42
William Demant Holdings (WILYY) Denmark $7.898B 0.00
Hill-Rom Holdings (HRC) United States $7.538B 21.68
DiaSorin S.p.A (DSRLF) Italy $6.994B 0.00
Perrigo (PRGO) Ireland $6.650B 12.12
GN STORE NORD (GNNDY) Denmark $6.176B 31.91
Canopy Growth (CGC) Canada $5.181B 0.00
Haemonetics (HAE) United States $5.064B 31.17
Shandong Weigao Medical Polymer (SHWGF) China $5.020B 0.00
ICU Medical (ICUI) United States $4.310B 28.15
Quidel (QDEL) United States $3.924B 34.44
Neogen (NEOG) United States $3.257B 55.17
GW Pharmaceuticals (GWPH) United Kingdom $3.020B 0.00
NuVasive (NUVA) United States $2.817B 21.78
Agios Pharmaceuticals (AGIO) United States $2.786B 0.00
Envista Holdings (NVST) United States $2.605B 0.00
Hutchison China MediTech (HCM) Hong Kong, SAR China $2.466B 0.00
National Vision Holdings (EYE) United States $1.765B 29.73
AtriCure (ATRC) United States $1.455B 0.00
Cardiovascular Systems (CSII) United States $1.374B 0.00
TG Therapeutics (TGTX) United States $1.105B 0.00
Aurora Cannabis (ACB) Canada $1.037B 0.00
NanoString Technologies (NSTG) United States $0.996B 0.00
Phibro Animal Health (PAHC) United States $0.941B 18.62
VAREX IMAGING (VREX) United States $0.888B 18.45
Aphria (APHA) $0.853B 0.00
Cerus (CERS) United States $0.812B 0.00
DFB Healthcare Acquisitions (AHCO) United States $0.758B 136.31
InMode (INMD) Israel $0.751B 0.00
Omeros (OMER) United States $0.731B 0.00
PetIQ (PETQ) United States $0.713B 19.40
OraSure Technologies (OSUR) United States $0.665B 82.46
Quanterix (QTRX) United States $0.647B 0.00
LeMaitre Vascular (LMAT) United States $0.521B 29.33
Lantheus Holdings (LNTH) United States $0.514B 11.55
Surmodics (SRDX) United States $0.454B 52.16
Zynex (ZYXI) United States $0.403B 43.39
Meridian Bioscience (VIVO) United States $0.376B 15.14
Owens & Minor (OMI) United States $0.358B 9.79
Repro-Med Systems (KRMD) United States $0.347B 218.75
Vapotherm (VAPO) United States $0.342B 0.00
Organigram Holdings (OGI) Canada $0.317B 0.00
Utah Medical Products (UTMD) United States $0.312B 22.31
MacroGenics (MGNX) United States $0.263B 0.00
Cytosorbents (CTSO) United States $0.242B 0.00
Female Health (VERU) United States $0.212B 0.00
InfuSystems Holdings (INFU) United States $0.210B 175.17
BioLife Solutions (BLFS) United States $0.201B 122.88
Viemed Healthcare (VMD) United States $0.195B 22.00
Exagen (XGN) United States $0.170B 0.00
United Health Products (UEEC) United States $0.152B 0.00
HEXO (HEXO) $0.147B 0.00
Rockwell Medical (RMTI) United States $0.146B 0.00
Bovie Medical (APYX) United States $0.133B 0.00
Chembio Diagnostics (CEMI) United States $0.132B 0.00
Evolus (EOLS) United States $0.130B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.122B 0.00
Liberty Health Sciences (LHSIF) Canada $0.110B 0.00
Fonar (FONR) United States $0.096B 6.97
MTech Acquisition (KERN) United States $0.092B 0.00
Chimerix (CMRX) United States $0.089B 0.00
Brainsway (BWAY) Israel $0.082B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.073B 0.00
Nephros (NEPH) United States $0.066B 0.00
United-Guardian (UG) United States $0.063B 13.22
Green Organic Dutchman Holdings (TGODF) Canada $0.061B 0.00
Wound Management Technologies (SMTI) United States $0.054B 0.00
Surface Oncology (SURF) United States $0.053B 0.00
GUARDION HEALTH (GHSI) United States $0.041B 0.00
ImmuCell (ICCC) United States $0.029B 0.00
FSD PHARMA INC (HUGE) Canada $0.027B 0.00
NF Energy Saving (BIMI) China $0.023B 0.00
Trinity Biotech (TRIB) Ireland $0.022B 0.00
Akers Biosciences Inc (AKER) United States $0.016B 0.00
Myomo (MYO) United States $0.011B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.010B 0.00
Capricor Therapeutics (CAPR) United States $0.008B 0.00
Senestech (SNES) United States $0.005B 0.00
NeuroMetrix (NURO) United States $0.002B 0.00